Page 10 - Demo

36 %u010ceskoslovensk%u00e1 fyziologie 73/2025 %u010d. 2P%u0158EHLEDN%u00c9 %u010cL%u00c1NKYBIBLIOGRAPHY1. Abdul-Ghani MA, DeFronzo RA. Pathogenesis of insulin resistance in skeletal muscle. J Biomed Biotechnol. 2010;2010:476279.2. Arroyave-Ospina JC, Wu Z, Geng Y, Moshage H. Role of oxidative stress in the pathogenesis of non-alcoholic fatty liver disease: Implications for prevention and therapy. Antioxidants. 2021;10(2):174.3. Bostr%u00f6m P, Wu J, Jedrychowski MP, et al. A PGC1-%u03b1-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481 (7382):463%u2013468.4. Banzet S, Koulmann N, Simler N, et al. Control of gluconeogenic genes during intense/prolonged exercise: Hormone-independent effect of muscle-derived IL-6 on hepatic tissue and PEPCK mRNA. J Appl Physiol. 2009;107(6):1830%u20131839.5. Buechler C, Haberl EM, Rein-Fischboeck L, Aslanidis C. Adipokines in liver cirrhosis. Int J Mol Sci. 2017;18(7):1392.6. Chen M, Cao Y, Ji G, Zhang L. Lean nonalcoholic fatty liver disease and sarcopenia. Front Endocrinol. 2023;14:566392.7. Chen X, Ji Y, Liu R, et al. Mitochondrial dysfunction: Roles in skeletal muscle atrophy. J Transl Med. 2023;21:503.8. de Oliveira Dos Santos AR, de Oliveira Zanuso B, Miola VFB, et al. Adipokines, myokines, and hepatokines: Crosstalk and metabolic repercussions. Int J Mol Sci. 2021;22(5):2639.9. Delogu W, Caligiuri A, Provenzano A, et al. Myostatin regulates the fibrogenic phenotype of hepatic stellate cells via c-jun N-terminal kinase activation. Dig Liver Dis. 2019;51(10):1400%u20131408.10. Delli Bovi AP, Marciano F, Mandato C, Siano MA, Savoia M, Vajro P. Oxidative stress in non-alcoholic fatty liver disease: An updated mini review. Front Med (Lausanne). 2021;8:595371.11. Dumond Bourie A, Potier JB, Pinget M, Bouzakri K. Myokines: Crosstalk and consequences on liver physiopathology. Nutrients. 2023;15(7):1729.12. Elkina Y, von Haehling S, Anker SD, Springer J. The role of myostatin in muscle wasting: An overview. J Cachexia Sarcopenia Muscle. 2011;2(3):143%u2013151.13. Fujita S, Rasmussen BB, Cadenas JG, Grady JJ, Volpi E. Effect of insulin on human skeletal muscle protein synthesis is modulated by insulin-induced changes in muscle blood flow and amino acid availability. American J Physiol Endocrinol Metab. 2006;291(4).14. Gonzalez A, Huerta-Salgado C, Orozco-Aguilar J, et al. Role of oxidative stress in hepatic and extrahepatic dysfunctions during non-alcoholic fatty liver disease (NAFLD). Oxid Med Cell Longev. 2020;2020:1617805.15. Gonzalez-Gil AM, Elizondo-Montemayor L. The role of exercise in the interplay between myokines, hepatokines, osteokines, adipokines, and modulation of inflammation for energy substrate redistribution and fat mass loss: A review. Nutrients. 2020;12(6):1899.16. Jensen-Cody SO, Potthoff MJ. Hepatokines and metabolism: Deciphering communication from the liver. Mol Metab. 2021;44:101138.17. Keating SE, Sabag A, Hallsworth K, et al. Exercise in the management of metabolic-associated fatty liver disease (MAFLD) in adults: A position statement from Exercise and Sport Science Australia. Sports Med. 2023;53(12):2347%u201371.18. Kliewer SA, Mangelsdorf DJ. A dozen years of discovery: Insights into the physiology and pharmacology of FGF21. Cell Metab. 2019;29(2):246%u201353.19. Kuchay MS, Mart%u00ednez-Montoro JI, Kaur P, Fern%u00e1ndez-Garc%u00eda JC, Ramos-Molina B. Non-alcoholic fatty liver disease-related fibrosis and sarcopenia: an altered liver-muscle crosstalk leading to increased mortality risk. Ageing Res Rev. 2022;80:101696.20. Li X, Wang H. Multiple organs involved in the pathogenesis of non-alcoholic fatty liver disease. Cell Biosci. 2020;10:140.21. Liu XH, Pan JP, Bauman WA, Cardozo CP. AdipoRon prevents myostatin-induced upregulation of fatty acid synthesis and downregulation of insulin activity in a mouse hepatocyte line. Physiol Rep. 2019;7(13).22. Merli M, Lattanzi B, Aprile F. Sarcopenia in non-alcoholic fatty liver disease: targeting the real culprit? J Hepatol. 2015;63(2):309%u201311.23. Merli M, Lattanzi B, Aprile F. Sarcopenic obesity in fatty liver. Current Opinion in Clinical Nutrition and Metabolic Care. 2019;22(3):185%u201390.24. Merz KE, Thurmond DC. Role of skeletal muscle in insulin resistance and glucose uptake. Compr Physiol. 2020;10(3):785%u2013809.25. Miao X, Alidadipour A, Saed V, et al. Hepatokines: Unveiling the molecular and cellular mechanisms connecting hepatic tissue to insulin resistance and inflammation. Acta Diabetol. 2024.26. Morales PE, Bucarey JL, Espinosa A. Muscle lipid metabolism: role of lipid droplets and perilipins. J Diabetes Res. 2017;2017:1789395.27. Nishikawa H, Enomoto H, Ishii A, et al. Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosis. J Cachexia Sarcopenia Muscle. 2017;8(6):915%u201325.28. Padda J, Khalid K, Khedr A, et al. Sarcopenia: an overview of the pathophysiology, risk factors, diagnosis and its management. Cureus. 2022;14(5).29. Pal D, Dasgupta S, Kundu R, et al. Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat Med. 2012;18(8):1279%u201385.30. Perakakis N, Triantafyllou GA, Fern%u00e1ndez-Real JM, et al. Physiology and role of irisin in glucose homeostasis. Nat Rev Endocrinol. 2017;13(6):324%u201337.31. Reza MM, Subramaniyam N, Sim CM, et al. Irisin is a pro-myogenic factor that induces skeletal muscle hypertrophy and rescues denervation-induced atrophy. Nat Commun. 2017;8(1):1104.32. Seo DY, Park SH, Marquez J, et al. Hepatokines as a molecular transducer of exercise. J Clin Med. 2021;10(3):385.33. Severinsen MCK, Pedersen BK. Muscle-organ crosstalk: the emerging roles of myokines. Endocr Rev. 2020;41(4):594%u2013609.34. Shen S, Liao Q, Chen X, Peng C, Lin L. The role of irisin in metabolic flexibility: beyond adipose tissue browning. Drug Discov Today. 2022;27(8):2261%u201367.35. Tang H, Yu R, Liu S, Huwatibieke B, Li Z, Zhang W. Irisin Inhibits Hepatic Cholesterol Synthesis via AMPK-SREBP2 Signaling. EBioMedicine. 2016;6:139%u201348.36. Tu Y, Liu J, Kong D, et al. Irisin drives macrophage anti-inflammatory differentiation via JAK2-STAT6-dependent activation of PPAR%u03b3 and Nrf2 signaling. Free Radic Biol Med. 2023;201:98%u2013110. 37. van der Windt DJ, Sud V, Zhang H, et al. The effects of physical exercise on fatty liver disease. Gene Expr. 2018;18(2):89%u2013101.38. Veskovi%u0107 M, %u0160utulovi%u0107 N, Hrn%u010di%u0107 D, et al. The interconnection between hepatic insulin resistance and metabolic dysfunction-associated steatotic liver disease: The transition from an adipocentric to liver-centric approach. Curr Issues Mol Biol. 2023;45(11):9084-9102.39. Yano N, Zhao YT, Zhao TC. The physiological role of irisin in the regulation of muscle glucose homeostasis. Endocrines. 2021;2(3):266%u201383.40. Zhao Q, Yin Y, Deng Y. Metabolic-associated fatty liver disease and sarcopenia additively increase mortality: a real-world study. Nutr&Diabetes. 2023;13:21.41. Ziolkowska S, Binienda A, Jab%u0142kowski M, et al. The interplay between insulin resistance, inflammation, oxidative stress, base excision repair, and metabolic syndrome in non-alcoholic fatty liver disease. Int J Mol Sci. 2021;22(20):11128.